This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Foreign product alert

Foreign Product Alerts: Protein Extract and artiphen

Starting date:
November 8, 2013
Posting date:
November 8, 2013
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Issue:
Undeclared Substance
Audience:
General Public
Identification number:
RA-36237

Introduction

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Affected products

  • Protein Extract
  • artriphen

Protein Extract 

Product description

This product is packaged in 1 oz and 4 oz amber glass bottles. Affected lot numbers include 243, 050812 and 012712A and are printed on the bottom of the front panel to the right. 

Hazard identified

The U.S. Food and Drug Administration warned consumers not to use this product after it was found to contain milk and soy allergen ingredients were not listed on the product’s main label. Undeclared milk and soy allergens may pose serious health risks to users of the product.  

Place of origin

This product is manufactured by Pure Herbs Ltd., Sterling Heights, MI, U.S.A.

Side effects

An allergic reaction occurs when the body’s immune system reacts to a foreign substance. The reaction can range from mild to life-threatening (i.e. an anaphylactic reaction). A mild reaction includes itchy and/or runny eyes and nose, skin rash and sneezing.

A severe reaction includes swelling, difficulty breathing and/or swallowing, dizziness, a sudden drop in blood pressure and loss of consciousness.

artriphen 

Product description

This product is promoted for the support of healthy joint function.  

Hazard identified

The U.S. Food and Drug Administration warned consumers not to use this product as it was found to contain milk and soy allergens. Undeclared milk and soy allergens may pose serious health risks to users of the product.

Place of origin

This product is manufactured by Xymogen, Orlando, Fla. U.S.A. 

Side effects

An allergic reaction occurs when the body’s immune system reacts to a foreign substance. The reaction can range from mild to life-threatening (i.e. an anaphylactic reaction). A mild reaction includes itchy and/or runny eyes and nose, skin rash and sneezing.

A severe reaction includes swelling, difficulty breathing and/or swallowing, dizziness, a sudden drop in blood pressure and loss of consciousness.

What you should do

Canadians who possess any of the products listed above are advised not to use them, and should consult with a health care professional if they have concerns about their health related to the use of these products.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the products listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of October 25, 2013, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax

Media enquiries

Health Canada

(613) 957-2983

Public enquiries

(613) 957-2991

1-866 225-0709

Images

Select thumbnail to enlarge - opens in a new window